瑞马迎春贺新岁 We welcome the Year of the Horse!
CMC specialist focused on technical leadership, process & analytical development, commercialization readiness, and alliance management.
CMC
Daniel joined Dark Horse Consulting in 2025, bringing CMC expertise in early- and late-stage gene therapy. His experience spans process & analytical development, tech transfer, comparability, regulatory authorship, and project leadership.
Before joining Dark Horse Consulting, Daniel spent several years at AviadoBio, where he primarily led the CMC strategy for the company’s lead AAV program, AVB-101. Over increasing positions, he executed broad CMC development, comparability planning, clinical trial supply, COGs modelling, and commercialisation readiness activities. During his time at AviadoBio, he also led the development of a novel medical device designed for spinal delivery of gene therapies.
In 2019, Daniel joined the CMC-MSAT team at MeiraGTx and was pivotal in establishing the initial downscale manufacturing process and subsequent tech transfer of their AAV assets into GMP. To support an expanding pipeline, Daniel's focus then turned to process intensification, COGs optimisation and improving operational efficiencies.
Daniel's career began in 2016 at Pall Corporation where he supported the development of novel bioprocessing technologies, as well as the adaptation of modality-agnostic equipment to the emerging needs of cell and gene therapies. While at Pall Corporation, he also managed the Continuous Processing Consortium program, a cross-company initiative to develop a continuous, integrated, biologics manufacturing platform.
AgilePM Foundation
APMG International
Issued Mar 2021
Credential ID 2001008772
PRINCE2® Foundation Certification Training
AXELOS Global Best Practice
Issued Mar 2021
Credential ID GR656193472DL
AviadoBio
Associate Director, Technical Operations
Development Lead, Technical Operations
CMC Project Manager
MeiraGTx
Project Manager - MSAT
City of London, England, United Kingdom
Process Development Scientist - Gene Therapy
Pall Corporation
Biotech Process R&D Scientist
University of Portsmouth
Master’s Degree, (MRes) Biochemistry and Molecular Biology
High Distinction
Masters of Research
University of Portsmouth
Bachelor of Science (BSc) Biology, Biochemistry, Biophysics and Molecular Biology
First Class Honours
